IFNG and head and neck squamous cell carcinoma: A possibility is that the IFN-γ-related mRNA expression profile is a predictor of the clinical response to anti-PD-1 therapy in HNSCC [12] and it was proposed to measure the levels of IFN-γ together with those of PD-L1 to identify the subjects most likely to respond to immunotherapy [13].